首页> 外文期刊>Retina >Endoscopic vitreoretinal surgery for complicated proliferative diabetic retinopathy.
【24h】

Endoscopic vitreoretinal surgery for complicated proliferative diabetic retinopathy.

机译:内镜玻璃体视网膜手术治疗复杂性增生性糖尿病视网膜病变。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: To evaluate the indication for endoscopic vitreoretinal surgery in proliferative diabetic retinopathy (PDR). METHODS: Chart review of consecutive cases of vitreoretinal surgery for PDR performed by one of the authors (Y.L.F.) over a 2-year period. RESULTS: Endoscopic vitreoretinal surgery was performed in 8 of 41 (19.5%) eyes. The surgical indications were small pupil (3), hyphema (3), pseudophakia with fibrotic posterior capsule (1), and pars plana neovascularization with anterior tractional retinal detachment (6). CONCLUSION: Endoscopic vitreoretinal surgery, by enhancing the visualization of the retroirideal space, is a useful technique in PDR with opaque ocular media and/or neovascularization of the pars plana and ciliary body.
机译:目的:评估内镜性玻璃体视网膜手术治疗增生性糖尿病视网膜病变(PDR)的适应症。方法:由一位作者(Y.L.F.)在2年的时间内连续进行PDR玻璃体视网膜手术病例的图表回顾。结果:在41只眼中有8只(19.5%)进行了内窥镜玻璃体视网膜手术。手术适应症包括小瞳孔(3),前房积血(3),假性晶状体伴纤维化后囊(1),以及平面前部新血管形成并伴有前牵引性视网膜脱离(6)。结论:内窥镜玻璃体视网膜手术通过增强后iriridealspace的可视化,是PDR的不透明眼球介质和/或平面和睫状体新血管形成的有用技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号